gliclazide has been researched along with chlorpropamide in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (31.82) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML | 1 |
| Harrower, AD | 2 |
| Boutagy, JS; Shenfield, GM; Webb, C | 1 |
| Conget, JI; Esmatjes, E; Halperin, I; Vendrell, J | 1 |
| Balabolkin, MI; Nedosugova, LV | 1 |
| Hatao, K; Kaku, K; Kaneko, T; Matsuda, M; Tsuchiya, M | 1 |
| Almér, LO | 2 |
| Fujii, T; Furukawa, H; Kawashima, K; Kuwashima, J; Kuzuya, T; Miyazaki, H; Nakamura, K; Watanabe, M | 1 |
| Selvaag, E | 1 |
| Abenhaim, L; Monette, J; van Staa, T | 1 |
| Fatehi, M; Lang, VY; Light, PE | 1 |
| Fernandes, C; Lima, Pde P; Soares, CD; Viana, IM | 1 |
| Algeelani, S; Alkhelb, D; Greenblatt, DJ | 1 |
1 review(s) available for gliclazide and chlorpropamide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
4 trial(s) available for gliclazide and chlorpropamide
| Article | Year |
|---|---|
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States | 1992 |
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide | 1991 |
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Simultaneous determination of oral antidiabetic drugs in human plasma using microextraction by packed sorbent and high-performance liquid chromatography.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Gliclazide; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Reproducibility of Results; Solid Phase Microextraction; Sulfonylurea Compounds | 2014 |
18 other study(ies) available for gliclazide and chlorpropamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A screening test for detecting sulfonylureas in plasma.
Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide | 1990 |
Gliclazide alcohol flush.
Topics: Chlorpropamide; Diabetes Mellitus, Type 2; Ethanol; Flushing; Gliclazide; Humans; Male; Middle Aged; Sulfonylurea Compounds | 1989 |
[Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gliclazide; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Insulin; Insulin Antibodies; Insulin Secretion; Leukocytes; Male; Middle Aged; Receptor, Insulin; Sulfonylurea Compounds | 1988 |
Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action.
Topics: Acetohexamide; Animals; Buformin; Chlorpropamide; Fructosediphosphates; Gliclazide; Gluconeogenesis; Glyburide; Glycolysis; Hexosediphosphates; In Vitro Techniques; Liver; Male; Rats; Rats, Inbred Strains; Stimulation, Chemical; Sulfamethoxazole; Sulfonylurea Compounds; Tolbutamide | 1985 |
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
Topics: alpha-Macroglobulins; Blood Vessels; Chlorpropamide; Diabetes Mellitus; Endothelium; Fibrinolysis; Gliclazide; Glipizide; Humans; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds | 1980 |
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
Topics: Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Endothelium; Female; Fibrinogen; Fibrinolysis; Gliclazide; Humans; Liver; Male; Middle Aged; Muscle, Smooth, Vascular; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds | 1984 |
Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Blood Glucose; Chlorpropamide; Drug Interactions; Gliclazide; Humans; Hypoglycemic Agents; Male; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin; Sulfonylurea Compounds | 1983 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Rates of hypoglycemia in users of sulfonylureas.
Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide | 1997 |
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gliclazide; Glyburide; Haplotypes; Homozygote; Humans; Isoindoles; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Inhibitory effects of sulfonylureas and non-steroidal anti-inflammatory drugs on in vitro metabolism of canagliflozin in human liver microsomes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Canagliflozin; Chlorpropamide; Diclofenac; Dose-Response Relationship, Drug; Drug Interactions; Gliclazide; Humans; Hypoglycemic Agents; Microsomes, Liver; Niflumic Acid; Sulfonylurea Compounds | 2018 |